Meta Health (Catalist:5DX) - Aandelenkoers, Nieuws & Analyse

5DX Overzicht aandelen

Meta Health Limited, een investeringsholding, houdt zich bezig met metaalstempelen en de productie van gereedschappen en opspanmiddelen in Singapore, Thailand, Maleisië en China. Meer informatie

5DX fundamentele analyse
Sneeuwvlok Score
Waardering	0/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	0/6
Dividenden	0/6

Risicoanalyse

Heeft minder dan 1 jaar cash runway

Negatief eigen vermogen

Zeer volatiele aandelenkoers in de afgelopen 3 maanden

Heeft geen betekenisvolle marktkapitalisatie ( SGD7M )

+ 2 meer risico's

Meta Health Limited Concurrenten

Santak Holdings

Catalist:580

S$7.5m

Darco Water Technologies

SGX:BLR

S$7.5m

China Kunda Technology Holdings

Catalist:GU5

S$6.1m

Fuji Offset Plates Manufacturing

Catalist:508

S$11.5m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Meta Health
Historische aandelenkoersen
Huidige aandelenkoers	S$0.007
52 Week Hoogtepunt	S$0.012
52 Week Laag	S$0.007
Bèta	0.90
11 maand verandering	-22.22%
3 maanden verandering	-12.50%
1 Jaar Verandering	-30.00%
33 jaar verandering	-87.04%
5 jaar verandering	-78.13%
Verandering sinds IPO	-98.44%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	5DX	SG Machinery	SG Markt
7D	0%	3.9%	0.007%
1Y	-30.0%	28.0%	14.5%

Rendement versus industrie: 5DX presteerde slechter dan de SG Machinery -sector, die het afgelopen jaar een rendement van 28 % opleverde.

Rendement versus markt: 5DX presteerde slechter dan SG Market, dat het afgelopen jaar een rendement van 14.5 % opleverde.

Prijsvolatiliteit

Is 5DX's price volatile compared to industry and market?
5DX volatility
5DX Average Weekly Movement	15.0%
Machinery Industry Average Movement	5.0%
Market Average Movement	4.4%
10% most volatile stocks in SG Market	14.8%
10% least volatile stocks in SG Market	2.2%

Stabiele aandelenkoers: De aandelenkoers van 5DX is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 15% ) van 5DX is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen SG.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
n/a	n/a	Bernard Ng	www.metahealth.sg

Meta Health Limited, een investeringsholding, houdt zich bezig met metaalstempelen en de productie van gereedschappen en armaturen in Singapore, Thailand, Maleisië en China. Het bedrijf is actief in twee segmenten, metaal en gezondheidszorg. Het bedrijf heeft ook een IoT-platform dat nodig is voor het beheer van chronische ziekten, een smart hospital-platform voor secundaire tot tertiaire ziekenhuizen, een sociaal e-commerce platform voor groepsaankopen en biedt diensten voor klinieken en thuiszorg.

Meta Health Limited Samenvatting

Hoe verhouden de winst en inkomsten van Meta Health zich tot de beurswaarde?
5DX fundamentele statistieken
Marktkapitalisatie	S$7.22m
Inkomsten(TTM)	-S$1.94m
Inkomsten(TTM)	S$252.39k

28.6x

P/S-verhouding

-3.7x

Koers/Winstverhouding

Is 5DX overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
5DX resultatenrekening (TTM)
Inkomsten	S$252.39k
Kosten van inkomsten	S$195.91k
Brutowinst	S$56.49k
Overige uitgaven	S$2.00m
Inkomsten	-S$1.94m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.0019
Brutomarge	22.38%
Nettowinstmarge	-769.69%
Schuld/Eigen Vermogen Verhouding	-216.9%

Hoe presteerde 5DX op de lange termijn?

Bekijk historische prestaties en vergelijking

5DX Overzicht aandelen

Risicoanalyse

Meta Health Limited Concurrenten

Catalist:580

S$7.5m

SGX:BLR

S$7.5m

Catalist:GU5

S$6.1m

Catalist:508

S$11.5m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Meta Health Limited (Catalist:5DX) completed the acquisition of 55% stake in Jas Medical Screening Centre Pte Ltd from Lian Ah Lek for SGD 0.68 million.

New major risk - Revenue size

First half 2024 earnings released: EPS: S$0 (vs S$0.004 loss in 1H 2023)

New major risk - Share price stability

Meta Health Limited Announces the Appointment of Cheah You Kong as the Acting Head of Finance and as an Executive Officer, Effective May 1, 2024

Meta Health Limited, Annual General Meeting, Apr 29, 2024

Recent updates

Meta Health Limited (Catalist:5DX) completed the acquisition of 55% stake in Jas Medical Screening Centre Pte Ltd from Lian Ah Lek for SGD 0.68 million.

New major risk - Revenue size

First half 2024 earnings released: EPS: S$0 (vs S$0.004 loss in 1H 2023)

New major risk - Share price stability

Meta Health Limited Announces the Appointment of Cheah You Kong as the Acting Head of Finance and as an Executive Officer, Effective May 1, 2024

Meta Health Limited, Annual General Meeting, Apr 29, 2024

High number of new directors

Meta Health Limited Announces Resignation of Tan Sze Leng as Chief Financial Officer, Effective from 17 May 2024

New major risk - Negative shareholders equity

Full year 2023 earnings released: S$0.004 loss per share (vs S$0.016 loss in FY 2022)

New minor risk - Financial data availability

Meta Health Limited Announces the Cessation of Mr. Chua Kheng Choon as Senior Vice President of Engineering

High number of new and inexperienced directors

New major risk - Shareholder dilution

High number of new and inexperienced directors

Meta Health Limited Appoints Lim Qing Ru as Independent Non-Executive Director, Member of the Audit Committee, the Nominating Committee and the Remuneration Committee, Effective from 1 November 2023

New major risk - Share price stability

New major risk - Revenue and earnings growth

First half 2023 earnings released: S$0.004 loss per share (vs S$0.005 loss in 1H 2022)

New major risk - Share price stability

Full year 2022 earnings released: S$0.013 loss per share (vs S$0.018 profit in FY 2021)

Meta Health Limited to Report Fiscal Year 2022 Results on Mar 01, 2023

Meta Health Limited Announces Resignation of Mak Peng Leong Philip as Joint Company Secretary, Effect from 12 December 2022

Executive Chairman & Group CEO recently bought S$59k worth of stock

Meta Health Limited Appoints Tan Sze Leng as Chief Financial Officer, Effective from 21 September 2022

Executive Chairman & Group CEO recently bought S$59k worth of stock

First half 2022 earnings released

Meta Health Limited Provides Financial Guidance for the First Half Year Ended June 30, 2022

High number of new and inexperienced directors

Meta Health Limited Announces Appointment of Law Ren Kai Kenneth as Independent Non-Executive Director, Chairman of the Audit Committee, and A Member of the Nominating Committee and the Remuneration Committee

Meta Health Limited Announces Resignation of Mak Peng Leong Philip as Joint Company Secretary, Effective 12 December 2022

Meta Health Limited Announces Resignation Leow Siew Yon, Cynthia as Independent Non-Executive Director, Chairman of the Nominating Committee, and a Member of the Audit Committee and the Remuneration Committee

Meta Health Limited Announces Management Changes

Full year 2021 earnings released: EPS: S$0.018 (vs S$0.005 loss in FY 2020)

Meta Health Limited, Annual General Meeting, Apr 28, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Now 23% undervalued after recent price drop

Metal Precision Services Pte Ltd. completed the acquisition of 85.07% stake in Gainhealth Pte. Ltd. from Jagannathan Padmaja Sakthi, Fu Yijie and Yeo Kang Nian.

Metal Component Engineering Limited (Catalist:5DX) agreed to acquire Gainhealth Pte. Ltd. from Jagannathan Padmaja Sakthi, Fu Yijie and Yeo Kang Nian for SGD 11.1 million.

Metal Component Engineering Considers Potential Acquisition

Independent Non-Executive Director has left the company

Full year 2020 earnings released

Metal Component Engineering Limited Announces Board Changes, Effective January 1, 2021

Metal Component Engineering Limited Provides Group Earnings Guidance for the Half Year Ended 30 June 2020

Metal Component Engineering Limited to Report First Half, 2020 Results on Aug 14, 2020

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Meta Health Limited Samenvatting

28.6x

-3.7x

Inkomsten en omzet